Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization

International Journal of Cancer

Volumn 130, Issue 5, 2012, Pages 1098-1108

  Vandewoestyne, Mado ^a   Kumps, Candy ^b   Swerts, Katrien ^b   Menten, Björn ^b   Lammens, Tim ^b   Philippé, Jan ^b   De Preter, Katleen ^b   Laureys, Geneviève ^b   Van Roy, Nadine ^b   Speleman, Frank ^b   Deforce, Dieter ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

array comparative genomic hybridization; dissemination; laser capture microdissection; magnetic activated cell sorting; neuroblastoma; pre treatment risk assessment

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; CELL ISOLATION; CELL SELECTION; CHROMOSOME 17Q; CHROMOSOME DELETION; CHROMOSOME DELETION 11Q; CHROMOSOME DELETION 1P; CHROMOSOME DELETION 3P; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISSEMINATED CANCER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE AMPLIFICATION; GENE DOSAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LASER CAPTURE MICRODISSECTION; MAGNETIC ACTIVATED CELL SORTING; MICROARRAY ANALYSIS; MYCN GENE; NEUROBLASTOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

BONE MARROW; BONE MARROW NEOPLASMS; COMPARATIVE GENOMIC HYBRIDIZATION; FLOW CYTOMETRY; HUMANS; LASER CAPTURE MICRODISSECTION; NEUROBLASTOMA;

EID: 84155168977     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26133     Document Type: Article

References (38)

1. Park JR, Eggert A, Caron H,. Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am 2008; 55: 97-120. (Pubitemid 351173188)
2. Brodeur GM,. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003; 3: 203-16. (Pubitemid 37328872)
3. Maris JM, Hogarty MD, Bagatell R, Cohn SL,. Neuroblastoma. Lancet 2007; 369: 2106-20. (Pubitemid 46935947)
4. Mueller S, Matthay KK,. Neuroblastoma: biology and staging. Curr Oncol Rep 2009; 1: 431-8.
5. Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, Kaneko M, London WB, Matthay KK, Nuchtern JG, von Schweinitz D, Simon T, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol 2009; 27: 298-303.
6. Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, Lequin D, Vermeulen J, Couturier J, Peuchmaur M, Valent A, Plantaz D, Rubie H, et al. Overall genomic pattern is a predictor of outcome in neuroblastoma. J Clin Oncol 2009; 27: 1026-33.
7. Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, Atkinson JB, Selch M, Gerbing RB, Stram DO, Lukens J,. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol 2000; 18: 477-86. (Pubitemid 30078529)
8. Shinawi M, Cheung SW,. The array CGH and its clinical applications. Drug Discov Today 2008; 13: 760-770.
9. Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI,. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 1988; 6: 1874-81. (Pubitemid 19089071)
10. Ambros PF, Ambros IM,. Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 2001; 37: 492-504. (Pubitemid 33101388)
11. Swerts K, Ambros PF, Brouzes C, Navarro JM, Gross N, Rampling D, Schumacher-Kuckelkorn R, Sementa AR, Ladenstein R, Beiske K,. Standardization of the immunocytochemical detection of neuroblastoma cells in bone marrow. J Histochem Cytochem 2005; 53: 1433-40. (Pubitemid 41720682)
12. Swerts K, Van Roy N, Benoit Y, Laureys G, Philippe J,. DRAQ5: improved flow cytometric DNA content analysis and minimal residual disease detection in childhood malignancies. Clin Chim Acta 2007; 379: 154-7. (Pubitemid 46366966)
13. Schleiermacher G, Janoueix-Lerosey I, Combaret V, Derre J, Couturier J, Aurias A, Delattre O,. Combined 24-color karyotyping and comparative genomic hybridization analysis indicates predominant rearrangements of early replicating chromosome regions in neuroblastoma. Cancer Genet Cytogenet 2003; 141: 32-42. (Pubitemid 36165194)
14. Mosse YP, Greshock J, Margolin A, Naylor T, Cole K, Khazi D, Hii G, Winter C, Shahzad S, Asziz MU, Biegel JA, Weber BL, et al. High-resolution detection and mapping of genomic DNA alterations in neuroblastoma. Genes Chromosomes Cancer 2005; 43: 390-403. (Pubitemid 40946474)
15. Van Roy N, Laureys G, Cheng NC, Willem P, Opdenakker G, Versteeg R, Speleman F,. 1;17 translocations and other chromosome 17 rearrangements in human primary neuroblastoma tumors and cell lines. Genes Chromosomes Cancer 1994; 10: 103-114.
16. Vandewoestyne M, Van Hoofstat D, Van Nieuwerburgh F, Deforce D,. Automatic detection of spermatozoa for laser capture microdissection. Int J Legal Med 2009; 123: 169-75.
17. Vandewoestyne M, Van Hoofstat D, Van Nieuwerburgh F, Deforce D,. Suspension fluorescence in situ hybridization (S-FISH) combined with automatic detection and laser microdissection for STR profiling of male cells in male/female mixtures. Int J Legal Med 2009; 123: 441-7.
18. Geigl JB, Obenauf AC, Waldispuehl-Geigl J, Hoffmann EM, Auer M, Hormann M, Fischer M, Trajanoski Z, Schenk MA, Baumbusch LO, Speicher MR,. Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays. Nucleic Acids Res 2009; 37: e105.
19. Swerts K, De Moerloose B, Dhooge C, Brichard B, Benoit Y, Laureys G, Philippe J,. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry. Cytometry B Clin Cytom 2004; 61: 9-19. (Pubitemid 39223365)
20. De Preter K, Vandesompele J, Heimann P, Yigit N, Beckman S, Schramm A, Eggert A, Stallings RL, Benoit Y, Renard M, De Paepe A, Laureys G, et al. Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes. Genome Biol 2006; 7: R84.
21. Menten B, Pattyn F, De Preter K, Robbrecht P, Michels E, Buysse K, Mortier G, De Paepe A, van Vooren S, Vermeesch J, Moreau Y, De Moor B, et al. arrayCGHbase: an analysis platform for comparative genomic hybridization microarrays. BMC Bioinformatics 2005; 6: 124.
22. Olshen AB, Venkatraman ES, Lucito R, Wigler M,. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004; 5: 557-72. (Pubitemid 41180205)
23. van de Wiel MA, Brosens R, Eilers PH, Kumps C, Meijer GA, Menten B, Sistermans E, Speleman F, Timmerman ME, Ylstra B,. Smoothing waves in array CGH tumor profiles. Bioinformatics 2009; 25: 1099-104.
24. De Brouwer S, De Preter K, Kumps C, Zabrocki P, Porcu M, Westerhout EM, Lakeman A, Vandesompele J, Hoebeeck J, Van Maerken T, De Paepe A, Laureys G, et al. Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification. Clin Cancer Res 2010; 16: 4353-4362.
25. Vermeulen J, De Preter K, Lefever S, Nuytens J, De Vloed F, Derveaux S, Hellemans J, Speleman F, Vandesompele J,. Measurable impact of RNA quality on gene expression results from quantitative PCR. Nucleic Acids Res, 2011; 39: e63.
26. van Houte BP, Binsl TW, Hettling H, Pirovano W, Heringa J,. CGHnormaliter: an iterative strategy to enhance normalization of array CGH data with imbalanced aberrations. BMC Genomics 2009; 10: 401.
27. George RE, Sanda T, Hanna M, Frohling S, Luther W, 2nd, Zhang J, Ahn Y, Zhou W, London WB, McGrady P, Xue L, Zozulya S, et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature 2008; 455: 975-8.
28. Chen Y, Takita J, Choi YL, Kato M, Ohira M, Sanada M, Wang L, Soda M, Kikuchi A, Igarashi T, Nakagawara A, Hayashi Y, et al. Oncogenic mutations of ALK kinase in neuroblastoma. Nature 2008; 455: 971-4.
29. Janoueix-Lerosey I, Lequin D, Brugieres L, Ribeiro A, de Pontual L, Combaret V, Raynal V, Puisieux A, Schleiermacher G, Pierron G, Valteau-Couanet D, Frebourg T, et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature 2008; 455: 967-70.
30. Caren H, Erichsen J, Olsson L, Enerback C, Sjoberg RM, Abrahamsson J, Kogner P, Martinsson T,. High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene. BMC Genomics 2008; 9: 353.
31. Lipinski M, Hirsch MR, Deagostini-Bazin H, Yamada O, Tursz T, Goridis C,. Characterization of neural cell adhesion molecules (NCAM) expressed by Ewing and neuroblastoma cell lines. Int J Cancer 1987; 40: 81-6. (Pubitemid 17099974)
32. Chang TK, Li CY, Smithson WA,. Immunocytochemical study of small round cell tumors in routinely processed specimens. Arch Pathol Lab Med 1989; 113: 1343-8. (Pubitemid 20027924)
33. Maris JM, Matthay KK,. Molecular biology of neuroblastoma. J Clin Oncol 1999; 17: 2264-79. (Pubitemid 29318861)
34. Ambros PF, Ambros IM, Brodeur GM, Haber M, Khan J, Nakagawara A, Schleiermacher G, Speleman F, Spitz R, London WB, Cohn SL, Pearson AD, et al. International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee. Br J Cancer 2009; 100: 1471-82.
35. De Preter K, Vandesompele J, Heimann P, Kockx MM, Van Gele M, Hoebeeck J, De Smet E, Demarche M, Laureys G, Van Roy N, De Paepe A, Speleman F,. Application of laser capture microdissection in genetic analysis of neuroblastoma and neuroblastoma precursor cells. Cancer Lett 2003; 197: 53-61. (Pubitemid 36859990)
36. Nishizaki T, DeVries S, Chew K, Goodson WH, 3rd, Ljung BM, Thor A, Waldman FM,. Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer 1997; 19: 267-72. (Pubitemid 27330238)
37. Qin LX, Tang ZY, Sham JS, Ma ZC, Ye SL, Zhou XD, Wu ZQ, Trent JM, Guan XY,. The association of chromosome 8p deletion and tumor metastasis in human hepatocellular carcinoma. Cancer Res 1999; 59: 5662-5.
38. Al-Mulla F, Keith WN, Pickford IR, Going JJ, Birnie GD,. Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer 1999; 24: 306-314. (Pubitemid 29115868)